Pediatric Palliative Care Drugs Market
Paediatric Palliative Care is the care given to children and their families who have been diagnosed with a life-limiting illness. Palliative care is more than just end-of-life care. It aims to improve a child's and family's quality of life by providing individualised care and assisting families in identifying and achieving their personal goals.
Over the forecast period, the market is expected to grow due to an increase in the number of rare diseases with pediatric onset. The rising prevalence of rare genetic diseases with pediatric onset drives up demand for pediatric palliative care drugs, which is expected to drive market growth over the forecast period. According to a September 2019 article published in the European Journal of Human Genetics, of the 6,172 clinically unique rare diseases described in Orphanet, an international reference knowledge base for rare diseases and orphan drugs, approximately 3,510 (69.9%) have exclusively pediatric onset and approximately 908 (18.2%) have onset spanning both adult and pediatric groups.
During the forecast period, the global Paediatric Palliative Care Drugs Market is expected to be hampered by a lack of awareness about palliative care. According to the Center to Advance Palliative Care's (CAPC) New Public Opinion Research from August 2019, palliative care is relatively unknown among the general public, but with proper education about palliative care, understanding and favorability may increase among consumers and physicians.
Market Segmentation:
By Drug Class
- Analgesics, Anti-emetics
- Laxatives
- Adjuvant Medications
- Steroids, Sedatives
- Neuroleptic Medications
- Others
By Route of Administration
- Oral
- Topical
- Parenteral
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The major players operating in the global pediatric palliative care drugs market include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co., Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
Source Link: https://www.einnews.com/pr_news/565193688/pediatric-palliative-care-drugs-market-is-poised-to-expand-at-a-5-1-cagr-by-2028-novartis-international-ag-mylan-nv
https://www.medgadget.com/2021/10/pediatric-palliative-care-drugs-market-growth-at-5-1-cagr-during-2021-2028-global-industry-growth-size-estimation-top-company-share-demand-regional-analysis-and-key-players-with-strategy-profilin.html